The overview of promising nonpharmacological treatments to improve the cognitive performance of schizophrenia patients

Schizophrenia is a complex neuropsychiatric disorder that could bring severe cognitive and neurological dysfunctions to patients. Current widely used treatments, such as second-generation antipsychotics, are only effective in addressing the positive symptoms of the disorder, rather than the negative symptoms and cognitive dysfunctions experienced by patients. Moreover, these medications lack personalized treatment, as they do not cater to the individual needs of each patient. Given these limitations, there is a pressing need to explore more innovative, nonpharmacological treatments that specifically target the improvement of negative and cognitive symptoms in schizophrenia patients. This paper, through literature review and case analysis, will delve into the various aspects of schizophrenia, including its symptoms, pathology, etiology, and diagnosis. Additionally, it will provide a comparative analysis of traditional and innovative treatment approaches, highlighting the potential benefits of exploring alternative, non-pharmacological interventions that may better address the multifaceted nature of this complex disorder.

Authors

Institutions

Publication Details

Journal
Theoretical and Natural Science
Published
2024-12-06
DOI
https://doi.org/10.54254/2753-8818/2024.18008
Primary Topic
Schizophrenia research and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The overview of promising nonpharmacological treatments to improve the cognitive performance of schizophrenia patients

Rui S. Xiao
Theoretical and Natural Science
Schizophrenia research and treatment
article

The overview of promising nonpharmacological treatments to improve the cognitive performance of schizophrenia patients

Rui S. Xiao
article en

Abstract

Schizophrenia is a complex neuropsychiatric disorder that could bring severe cognitive and neurological dysfunctions to patients. Current widely used treatments, such as second-generation antipsychotics, are only effective in addressing the positive symptoms of the disorder, rather than the negative symptoms and cognitive dysfunctions experienced by patients. Moreover, these medications lack personalized treatment, as they do not cater to the individual needs of each patient. Given these limitations, there is a pressing need to explore more innovative, nonpharmacological treatments that specifically target the improvement of negative and cognitive symptoms in schizophrenia patients. This paper, through literature review and case analysis, will delve into the various aspects of schizophrenia, including its symptoms, pathology, etiology, and diagnosis. Additionally, it will provide a comparative analysis of traditional and innovative treatment approaches, highlighting the potential benefits of exploring alternative, non-pharmacological interventions that may better address the multifaceted nature of this complex disorder.

Theoretical and Natural ScienceVol. 64(1)
University of California System (US)
Openalex Percentile: Top 70%
Schizophrenia research and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

The overview of promising nonpharmacological treatments to improve the cognitive performance of schizophrenia patients — Rui S. Xiao · Theoretical and Natural Science (2024) | TGRS Research Map | TGRS